Literature DB >> 15710850

Fate of immortalized human neuronal progenitor cells transplanted in rat spinal cord.

Peiying Li1, Alan Tessler, Steve S W Han, Itzhak Fischer, Mahendra S Rao, Michael E Selzer.   

Abstract

BACKGROUND: Replacement of neurons and glia by transplantation has been proposed as a therapy for neurodegenerative diseases, including amyotrophic lateral sclerosis. This strategy requires using human motor neuronal progenitor cells or xenografts of animal cells, but there is little evidence that xenografted neuronal cells can survive in spinal cord despite immunosuppression.
OBJECTIVE: To clarify the mechanisms responsible for the death of xenografted neurons in spinal cord.
METHODS: Cells from an immortalized, neuronally committed, human embryonic spinal cord-derived cell line (HSP1) that expresses motor neuronal properties in vitro were transplanted into adult rat spinal cord. The rats were killed at intervals up to 8 weeks and serial sections through the graft sites were processed for immunofluorescence using primary antibodies against human nuclear and mitochondrial antigens, microtubule-associated protein 2, TUJ1, CD5, natural killer cells, and activated microglia-macrophages, caspase-3 and caspase-9.
RESULTS: Grafted cells did not migrate and underwent partial differentiation along a neuronal pathway. They were rejected after 4 weeks despite cyclosporine immunosuppression. Cells died by apoptosis via the cytochrome c/caspase-9/caspase-3 pathway. The host response included natural killer cells and activated microglia-macrophages but few T cells.
CONCLUSIONS: Intraspinal neuronal xenotransplantation failed because of apoptotic cell death. Neither T cells nor the spinal cord environment, which favors gliogenesis, are likely to have been responsible, but natural killer cells may have been involved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710850     DOI: 10.1001/archneur.62.2.223

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

1.  Tetrahedral DNA nanostructures facilitate neural stem cell migration via activating RHOA/ROCK2 signalling pathway.

Authors:  Wenjuan Ma; Xueping Xie; Xiaoru Shao; Yuxin Zhang; Chenchen Mao; Yuxi Zhan; Dan Zhao; Mengting Liu; Qianshun Li; Yunfeng Lin
Journal:  Cell Prolif       Date:  2018-08-09       Impact factor: 6.831

2.  Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis.

Authors:  Amit K Srivastava; Sarah K Gross; Akshata A Almad; Camille A Bulte; Nicholas J Maragakis; Jeff W M Bulte
Journal:  Exp Neurol       Date:  2016-12-28       Impact factor: 5.330

3.  Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Authors:  Aman Khurana; Hossein Nejadnik; Fanny Chapelin; Olga Lenkov; Rakhee Gawande; Sungmin Lee; Sandeep N Gupta; Nooshin Aflakian; Nikita Derugin; Solomon Messing; Guiting Lin; Tom F Lue; Laura Pisani; Heike E Daldrup-Link
Journal:  Nanomedicine (Lond)       Date:  2013-03-27       Impact factor: 5.307

4.  Harvested human neurons engineered as live nervous tissue constructs: implications for transplantation. Laboratory investigation.

Authors:  Jason H Huang; Eric L Zager; Jun Zhang; Robert F Groff; Bryan J Pfister; Akiva S Cohen; M Sean Grady; Eileen Maloney-Wilensky; Douglas H Smith
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

5.  Cell-Based Neurorestorotherapy in Amyotrophic Lateral Sclerosis - Scientific Truth should Rely on Facts, but Not Conjecture.

Authors:  Lin Chen; Haitao Xi; Hongyun Huang
Journal:  Front Integr Neurosci       Date:  2011-12-20

6.  Impurity of stem cell graft by murine embryonic fibroblasts - implications for cell-based therapy of the central nervous system.

Authors:  Marek Molcanyi; Narges Zare Mehrjardi; Ute Schäfer; Nadia Nabil Haj-Yasein; Michael Brockmann; Marina Penner; Peter Riess; Clemens Reinshagen; Bernhard Rieger; Tobias Hannes; Jürgen Hescheler; Bert Bosche
Journal:  Front Cell Neurosci       Date:  2014-09-05       Impact factor: 5.505

Review 7.  History of Neural Stem Cell Research and Its Clinical Application.

Authors:  Yasushi Takagi
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-02-16       Impact factor: 1.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.